Angiodynamics (ANGO) Current Deferred Revenue (2012 - 2014)

Angiodynamics (ANGO) has reported Current Deferred Revenue for 3 consecutive years, with $1.5 million the latest figure, recorded in Q1 2014.

• For the quarter ending Q1 2014, Current Deferred Revenue changed N/A year-over-year to $1.5 million; the trailing twelve-month figure through Feb 2014 stood at $1.5 million (changed N/A YoY), and the FY2013 full-year result was $1.6 million, down 49.87% from the prior year.
• Current Deferred Revenue fell to $1.5 million in Q1 2014 per ANGO's latest filing, from $1.6 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $3.3 million in Q3 2012 and bottomed at $1.5 million in Q1 2014.
• Historically, Current Deferred Revenue has averaged $2.1 million across 3 years, with a median of $1.6 million in 2013.
• The widest YoY moves for Current Deferred Revenue: up 49.87% in 2013, down 52.41% in 2013.
• Over 3 years, Current Deferred Revenue stood at $3.3 million in 2012, then plunged by 51.63% to $1.6 million in 2013, then retreated by 8.97% to $1.5 million in 2014.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $1.5 million, $1.6 million, and $1.6 million for Q1 2014, Q4 2013, and Q3 2013 respectively.